Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigational Use of Erenumab for the Treatment of Fibromyalgia Pain

NCT06411067 is registered in ClinicalTrials.gov with United States Naval Medical Center, Portsmouth as lead sponsor.

NCT NCT06411067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06411067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigational Use of Erenumab for the Treatment of Fibromyalgia Pain
Lead sponsor
United States Naval Medical Center, Portsmouth
Phase
Phase 3
Overall status
Withdrawn
Start date
February 26, 2020
Completion date
May 9, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia